Abstract
Cancer represents a major medical challenge of our time, exacerbated by the paradoxical combination of an age-related increase in cancer incidence and a demographic shift towards older populations worldwide. During the last 10 years, significantly improved strategies for molecular cancer prevention and targeted therapeutic intervention have become available, an encouraging sign indicating that decades of global commitment to biomedical research, implementing what is now known as the biological revolution of the late twentieth century, start bearing fruit for cancer patients and survivors. It has now become apparent that oncogene-driven tumorigenesis is associated with specific stress phenotypes including DNA damage stress, mitotic stress, metabolic stress, proteotoxic stress, and oxidative stress. Importantly, cancer cells depend on the counter-regulatory activation of cytoprotective stress response pathways enabling adaptive capabilities that antagonize the cytotoxic consequences of oncogenesis-associated cellular stresses, and cumulative research indicates that the essential nature of these stress response pathways represents a specific molecular vulnerability amenable to therapeutic intervention targeting this emerging Achilles heel of malignancy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Benbrook DM, Long A (2012) Integration of autophagy, proteasomal degradation, unfolded protein response and apoptosis. Exp Oncol 34:286–297
Chan DA, Giaccia AJ (2011) Harnessing synthetic lethal interactions in anticancer drug discovery. Nat Rev Drug Discov 10:351–364
Dai C, Dai S, Cao J (2012) Proteotoxic stress of cancer: implication of the heat-shock response in oncogenesis. J Cell Physiol 227(8):2982–2987
De Raedt T, Walton Z, Yecies JL, Li D, Chen Y, Malone CF, Maertens O, Jeong SM, Bronson RT, Lebleu V, Kalluri R, Normant E, Haigis MC, Manning BD, Wong KK, Macleod KF, Cichowski K (2011) Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell 20:400–413
Grbovic OM, Basso AD, Sawai A, Ye Q, Friedlander P, Solit D, Rosen N (2006) V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors. Proc Natl Acad Sci U S A 103:57–62
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Healy SJ, Gorman AM, Mousavi-Shafaei P, Gupta S, Samali A (2009) Targeting the endoplasmic reticulum-stress response as an anticancer strategy. Eur J Pharmacol 625:234–246
Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell 13:472–482
Luo J, Solimini NL, Elledge SJ (2009) Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136:823–837
Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr, Lee KP, Boise LH (2006) Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107:4907–4916
Qiao S, Lamore SD, Cabello CM, Lesson JL, Munoz-Rodriguez JL, Wondrak GT (2012) Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes. Biochem Pharmacol 83:1229–1240
Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SW (2011) Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475:231–234
Shaheen M, Allen C, Nickoloff JA, Hromas R (2011) Synthetic lethality: exploiting the addiction of cancer to DNA repair. Blood 117:6074–6082
Wondrak GT (2009) Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 11:3013–3069
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Wondrak, G.T. (2015). Introduction to Cell Stress Responses in Cancer: The Big Picture. In: Wondrak, G. (eds) Stress Response Pathways in Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9421-3_1
Download citation
DOI: https://doi.org/10.1007/978-94-017-9421-3_1
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-9420-6
Online ISBN: 978-94-017-9421-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)